Physician profile
Floyd Mitchell Smith
NPI 1063608065
$5,322.68
in general payments reported to CMS, 2019-2025
16 companies · $695 in 2025
The $695 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,520 · 2020: $382 · 2021: $679 · 2022: $710 · 2023: $566 · 2024: $769 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,031.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,121.72 | 2019-2025 | Dailies Total1, Precision 1, Tryptyr |
| Coopervision INC. | $1,339.20 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Sight Sciences, INC. | $317.85 | 2020-2022 | |
| Glaukos Corporation | $316.59 | 2024-2025 | Idosetr, Photrexa |
| Menicon America INC | $305.14 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $207.42 | 2019-2021 | |
| Allergan, INC. | $170.40 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $145.85 | 2022-2025 | Miebo, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $137.00 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $91.10 | 2021-2022 | |
| Oyster Point Pharma, INC. | $74.97 | 2022-2023 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $33.76 | 2019 | |
| Eyevance Pharmaceuticals LLC | $18.13 | 2022 | |
| Abbvie INC. | $14.98 | 2022 | |
| Harrow Eye, LLC | $14.40 | 2025 | Vevye |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Floyd Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.